AtaiBeckley (ATAI) Retained Earnings (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Retained Earnings came in at -$20.6 million in Q1 2026, up 1.54% quarter-over-quarter from -$20.9 million in Q4 2025.
AtaiBeckley (ATAI) Retained Earnings (2020 - 2026) Analysis & Trends
AtaiBeckley's Retained Earnings history runs 3 years deep, the most recent figure standing at -$20.6 million for Q1 2026.
- On a quarterly basis, Retained Earnings changed N/A year-over-year to -$20.6 million in Q1 2026; TTM through Mar 2026 was -$20.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$20.9 million, down 102.56% from the prior year.
- Retained Earnings grew to -$20.6 million in Q1 2026 per ATAI's latest filing, from -$20.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $875.7 million in Q1 2025 to a low of -$815.4 million in Q3 2025.
- A 5-year average of $123.4 million and a median of -$20.8 million in 2023 frame the typical range for Retained Earnings.
- Biggest YoY gain for Retained Earnings was 102.56% in 2025; the steepest drop was 102.56% in 2025.
- Year by year, Retained Earnings stood at $816.2 million in 2024, then tumbled by 102.56% to -$20.9 million in 2025, then increased by 1.54% to -$20.6 million in 2026.
- Per Business Quant, the three latest ATAI Retained Earnings figures stand at -$20.6 million (Q1 2026), -$20.9 million (Q4 2025), and $816.2 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | -24.89 Mn |
| 10 | AtaiBeckley | 1.56 Bn | 1.56 Bn | - | -815.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.60 Mn |
| Dec 31, 2025 | -20.93 Mn |
| Sep 30, 2025 | -815.40 Mn |
| Jun 30, 2025 | -754.37 Mn |
| Mar 31, 2025 | 875.72 Mn |
| Dec 31, 2024 | 816.19 Mn |
| Dec 31, 2024 | 816.19 Mn |
| Sep 30, 2024 | -661.20 Mn |
| Jun 30, 2024 | -634.96 Mn |
| Mar 31, 2024 | 800.52 Mn |
| Dec 31, 2023 | 794.79 Mn |
| Jun 30, 2023 | -20.82 Mn |
| Mar 31, 2023 | -543.85 Mn |
| Dec 31, 2022 | -21.70 Mn |
| Sep 30, 2022 | 761.81 Mn |
| Jun 30, 2022 | -431.30 Mn |
| Mar 31, 2022 | 735.38 Mn |
| Dec 31, 2021 | 725.05 Mn |
| Sep 30, 2021 | 709.48 Mn |
| Jun 30, 2021 | -237.77 Mn |